Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Al Baraka Pharmaceutical Industries is a leading private pharmaceutical company based in Algeria, specializing in the development, manufacturing, and marketing of generic medicines. Founded in 2006, the company operates a state-of-the-art manufacturing facility in Zeralda, Algiers, which adheres to international Good Manufacturing Practice (GMP) standards. Its extensive product portfolio covers a wide range of therapeutic areas, including cardiology, gastroenterology, neurology, diabetology, and pulmonology. Al Baraka Pharma plays a significant role in the Algerian healthcare market by providing high-quality, affordable alternatives to brand-name medications. The company also engages in strategic partnerships for the local production of international pharmaceutical brands under license.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Albaraka.